Liven Pharma Limited (KASE: LIVEN)
Health Care · Pharmaceuticals · PK
PKRs30.37
-2.47% today · -53.5% 1Y
Liven Pharma Limited (KASE: LIVEN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.40M.
Over the last twelve months the share price has lost 53.5%, trading between 27.82 and 70.68.
Tweenvest scores Liven Pharma Limited across four factors: quality 39/100, value 69/100, growth 0/100. Its strongest factor is value.
LIVEN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.40M
- Revenue (TTM)
- $380.61K
- P/E
- —
- EPS
- -0.28
- Dividend yield
- —
- Beta (5Y)
- -0.26
- 52-week high
- PKRs70.68
- 52-week low
- PKRs27.82
- Avg volume (3M)
- —
- Shares outstanding
- 113.04M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Intravenous Infusions PlcGHSE: IIL | $12.84M | GH₵0.55 | +12.24% |
| FLUENT Corp.CNSX: FNT.U | $12.76M | $0.02 | -20.00% |
| Biogened S.A.WSE: BGD | $12.41M | zł19.90 | +0.51% |
| Krebs Biochemicals & Industries LimitedBSE: 524518 | $12.41M | Rs55.72 | -19.71% |
| Alpa Laboratories LimitedNSEI: ALPA | $12.39M | Rs56.99 | -3.83% |
| Rize Oncology Inc.OTCPK: RZON.F | $12.12M | $— | — |
| ChoA Pharmaceutical Co., LTD.KOSDAQ: A034940 | $11.84M | ₩2,570.00 | -3.20% |
| Daré Bioscience, Inc.NasdaqCM: DARE | $11.82M | $0.74 | -4.56% |
Figures last refreshed Oct 11, 2026.